128 related articles for article (PubMed ID: 12885819)
21. Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review.
Rutherford C; King MT; Butow P; Legare F; Lyddiatt A; Souli I; Rincones O; Stacey D
Qual Life Res; 2019 Mar; 28(3):593-607. PubMed ID: 30426276
[TBL] [Abstract][Full Text] [Related]
22. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in end-stage COPD and lung cancer patients.
Habraken JM; ter Riet G; Gore JM; Greenstone MA; Weersink EJ; Bindels PJ; Willems DL
J Pain Symptom Manage; 2009 Jun; 37(6):973-81. PubMed ID: 19394792
[TBL] [Abstract][Full Text] [Related]
24. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.
Efficace F; Kemmler G; Vignetti M; Mandelli F; Molica S; Holzner B
Eur J Cancer; 2008 Jul; 44(11):1497-506. PubMed ID: 18555682
[TBL] [Abstract][Full Text] [Related]
26. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review.
Van Der Weijst L; Lievens Y; Schrauwen W; Surmont V
Front Oncol; 2019; 9():715. PubMed ID: 31456938
[No Abstract] [Full Text] [Related]
27. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
28. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Goss G; Paszat L; Newman TE; Evans WK; Browman G
Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
[TBL] [Abstract][Full Text] [Related]
29. A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life.
Maciejewski ML; Patrick DL; Williamson DF
J Clin Epidemiol; 2005 Jun; 58(6):568-78. PubMed ID: 15878470
[TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
32. Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC).
Schrimpf D; Manegold C; Pilz LR
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):84-6. PubMed ID: 23260009
[No Abstract] [Full Text] [Related]
33. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.
Kenny PM; King MT; Viney RC; Boyer MJ; Pollicino CA; McLean JM; Fulham MJ; McCaughan BC
J Clin Oncol; 2008 Jan; 26(2):233-41. PubMed ID: 18086802
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in patients surviving non-small cell lung cancer.
Grutters JP; Joore MA; Wiegman EM; Langendijk JA; de Ruysscher D; Hochstenbag M; Botterweck A; Lambin P; Pijls-Johannesma M
Thorax; 2010 Oct; 65(10):903-7. PubMed ID: 20861294
[TBL] [Abstract][Full Text] [Related]
35. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials.
Zikos E; Ghislain I; Coens C; Ediebah DE; Sloan E; Quinten C; Koller M; van Meerbeeck JP; Flechtner HH; Stupp R; Pallis A; Czimbalmos A; Sprangers MA; Bottomley A
Lancet Oncol; 2014 Feb; 15(2):e78-89. PubMed ID: 24480558
[TBL] [Abstract][Full Text] [Related]
38. Exercise interventions following surgery for non-small cell lung cancer (NSCLC): the need for future randomised controlled trials.
Granger C; Denehy L
Lung Cancer; 2010 Nov; 70(2):228-9. PubMed ID: 20832895
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
